Zacks Investment Research on MSN1 天
Alkermes Begins Idiopathic Hypersomnia Study on ALKS 2680
Alkermes plc ALKS announced that it has initiated the phase II Vibrance-3 study, evaluating the novel, investigational and ...
Clinical Trials Arena1 天
Alkermes begins Phase II trial of drug candidate for idiopathic hypersomnia
Alkermes has begun a randomised Phase II trial to assess the efficacy and safety of ALKS 2680 in adults with idiopathic ...
Alkermes initiates Phase 2 study evaluating ALKS 2680 in idopathic hypersomnia
Alkermes (ALKS) announced the initiation of Vibrance-3, a phase 2 clinical study evaluating the safety and efficacy of ALKS 2680 compared to ...
Onlymyhealth6 天
Does Idiopathic Hypersomnia Ever Go Away? Find Out From The Expert
Idiopathic hypersomnia is a neurological sleep disorder characterised by excessive daytime sleepiness despite getting a full ...
Hawaii's Kilauea volcano erupts again, no threat to residents
Lava fountains shoot up during the March 20, 2025 episode in the ongoing eruption of Kilauea. Sunita Williams on the future of space tourism 4 Romantic Malayalam movies to melt your heart this Tuesday ...
Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth ...
Advancing a broad, potential best-in-class orexin receptor 2 (OX2R) agonist franchise with key data readouts expected in 2025ORX750 Phase 2a ...
What is sleep latency?
Sleep latency is the term that describes the time it takes you to fall asleep. It’s thought that on average, we generally ...
Tired all the time? Sleep experts share how to tackle hypersomnia — plus what might be ...
Dr Leah Kaylor, a psychologist and sleep expert says: “Occasionally, more sleep may be required after emotionally intense ...